126 related articles for article (PubMed ID: 35247439)
21. The promoter hypermethylation of SULT2B1 accelerates esophagus tumorigenesis via downregulated PER1.
Li Z; Li MY; Wang LL; Li L; Chen QY; Zhu YH; Li Y; Qin YR; Guan XY
Thorac Cancer; 2021 Dec; 12(24):3370-3379. PubMed ID: 34730281
[TBL] [Abstract][Full Text] [Related]
22. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
[TBL] [Abstract][Full Text] [Related]
23. Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Cheng X; Wei L; Huang X; Zheng J; Shao M; Feng T; Li J; Han Y; Tan W; Tan W; Lin D; Wu C
Gastroenterology; 2017 Jun; 152(8):1985-1997.e12. PubMed ID: 28209530
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
26. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
27. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
29. S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway.
Liu Y; Zhi Y; Song H; Zong M; Yi J; Mao G; Chen L; Huang G
J Exp Clin Cancer Res; 2019 Aug; 38(1):369. PubMed ID: 31438989
[TBL] [Abstract][Full Text] [Related]
30. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.
Qi B; Wang Y; Chen ZJ; Li XN; Qi Y; Yang Y; Cui GH; Guo HZ; Li WH; Zhao S
World J Gastroenterol; 2017 Dec; 23(45):7965-7977. PubMed ID: 29259372
[TBL] [Abstract][Full Text] [Related]
32. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
33. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
[TBL] [Abstract][Full Text] [Related]
34. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma.
Li W; Zhang L; Guo B; Deng J; Wu S; Li F; Wang Y; Lu J; Zhou Y
Mol Cancer; 2019 Feb; 18(1):22. PubMed ID: 30736860
[TBL] [Abstract][Full Text] [Related]
35. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
[TBL] [Abstract][Full Text] [Related]
36. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
37. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
38. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
[TBL] [Abstract][Full Text] [Related]
39. Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma.
Chu J; Niu X; Chang J; Shao M; Peng L; Xi Y; Lin A; Wang C; Cui Q; Luo Y; Fan W; Chen Y; Sun Y; Guo W; Tan W; Lin D; Wu C
Theranostics; 2020; 10(8):3488-3502. PubMed ID: 32206103
[No Abstract] [Full Text] [Related]
40. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
